Apogee Therapeutics, Inc. APGE Short- and long-term operating lease liabilities
Short- and long-term operating lease liabilities at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apogee Therapeutics, Inc.'s short- and long-term operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apogee Therapeutics, Inc.'s short- and long-term operating lease liabilities?
- Apogee Therapeutics, Inc. (APGE) reported short- and long-term operating lease liabilities of -$802K in Q1 2026.
- How has Apogee Therapeutics, Inc.'s short- and long-term operating lease liabilities changed year-over-year?
- Apogee Therapeutics, Inc.'s short- and long-term operating lease liabilities increased by 20.9% year-over-year, from -$1.01M to -$802K.
- What is the long-term trend for Apogee Therapeutics, Inc.'s short- and long-term operating lease liabilities?
- Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s short- and long-term operating lease liabilities has grown at a 284.0% compound annual growth rate (CAGR), from -$270K to -$3.98M.